Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum Journal Article


Authors: Argani, P.; Yonescu, R.; Morsberger, L.; Morris, K.; Netto, G. J.; Smith, N.; Gonzalez, N.; Illei, P. B.; Ladanyi, M.; Griffin, C. A.
Article Title: Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum
Abstract: A subset of renal cell carcinomas (RCCs) is characterized by t(6;11)(p21;q12), which results in fusion of the untranslated Alpha (MALAT1) gene to the TFEB gene. Only 21 genetically confirmed cases of t(6;11) RCCs have been reported. This neoplasm typically demonstrates a distinctive biphasic morphology, comprising larger epithelioid cells and smaller cells clustered around basement membrane material; however, the full spectrum of its morphologic appearances is not known. The t(6;11) RCCs differ from most conventional RCCs in that they consistently express melanocytic immunohistochemical (IHC) markers such as HMB45 and Melan A and the cysteine protease cathepsin K but are often negative for epithelial markers such as cytokeratins. TFEB IHC has been proven to be useful to confirm the diagnosis of t(6;11) RCCs in archival material, because native TFEB is upregulated through promoter substitution by the gene fusion. However, IHC is highly fixation dependent and has been proven to be particularly difficult for TFEB. A validated fluorescence in situ hybridization (FISH) assay for molecular confirmation of the t(6;11) RCC in archival formalin-fixed, paraffin-embedded material has not been previously reported. We report herein the development of a break-apart TFEB FISH assay for the diagnosis of t(6;11)(p21;q12) RCCs. We validated the assay on 4 genetically confirmed cases and 76 relevant expected negative control cases and used the assay to report 8 new cases that expand the clinicopathologic spectrum of t(6;11) RCCs. An additional previously reported TFEB IHC-positive case was confirmed by TFEB FISH in 46-year-old archival material. In conclusion, TFEB FISH is a robust, clinically validated assay that can confirm the diagnosis of t(6;11) RCC in archival material and should allow a more comprehensive clinicopathologic delineation of this recently recognized neoplastic entity. Copyright © 2012 by Lippincott Williams &Wilkins.
Keywords: adolescent; adult; preschool child; child, preschool; middle aged; gene translocation; genetics; liver neoplasms; metabolism; in situ hybridization, fluorescence; metastasis; pathology; validation study; renal cell carcinoma; kidney carcinoma; kidney neoplasms; fluorescence in situ hybridization; dna; kidney tumor; carcinoma, renal cell; liver tumor; dna, neoplasm; chromosomes, human, pair 6; translocation, genetic; fish; chromosome 11; chromosome 6; chromosomes, human, pair 11; paraffin; paraffin embedding; translocation; tfe3; basic helix loop helix leucine zipper transcription factor; basic helix-loop-helix leucine zipper transcription factors; tfeb protein, human; tfeb
Journal Title: American Journal of Surgical Pathology
Volume: 36
Issue: 10
ISSN: 0147-5185
Publisher: Lippincott Williams & Wilkins  
Date Published: 2012-10-01
Start Page: 1516
End Page: 1526
Language: English
DOI: 10.1097/PAS.0b013e3182613d8f
PROVIDER: scopus
PUBMED: 22892601
PMCID: PMC4441265
DOI/URL:
Notes: --- - "Export Date: 2 November 2012" - "CODEN: AJSPD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Marc Ladanyi
    1328 Ladanyi